Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
life sciences
national blog main
boston
fda
alexion pharmaceuticals
ally bridge group
amyotrophic lateral sclerosis (als)
autoimmune disorders
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
cancer
cancer drugs
casdin capital
complement system
deals
deciphera pharmaceuticals
diabetic nephropathy
eli lilly
endometral cancer
europe blog main
european society for medical oncology
eventide asset management
focal segmental glomerulosclerosis
generalized myasthenia gravis
glioblastoma
goldfinch bio
immune-mediated necrotizing myopathy
irving investors
jay ghosh
loxo oncology
mirati therapeutics
national top stories
new enterprise associates
What
drug
3
×
lead
3
×
medicines
biotech
ipo
new
alternative
analysis
autoimmune
bio
black
bring
cancer
candidate
clinic
companies
company
deal
develop
diamond
disease
diseases
eluded
employing
expensive
genetic
goldfinch
hopes
kidney
later
leading
lines
million
molecular
nears
pharma
pharmaceuticals
phase
potential
ra
Language
unset
Current search:
lead
×
drug
×
" boston blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma